Streptococcus pneumoniae

Lore & Background

Streptococcus pneumoniae, often called the pneumococcus, appears under the microscope as a Gram-positive, spherical bacterium that typically arranges itself in pairs, known as diplococci. These cells are non-motile and do not form spores. On a Gram stain, they exhibit a distinctive lancet-shaped morphology. The bacterium is alpha-hemolytic on blood agar, meaning it partially breaks down red blood cells. Its defining feature is a polysaccharide capsule, which serves as a key virulence factor by forming the outermost layer of the cell. This capsule is composed of repeating oligosaccharide units linked to the cell wall and inhibits phagocytosis by blocking granulocytes from reaching the bacterial cell wall. More than one hundred different serotypes exist, distinguished by the chemical composition and quantity of capsular polysaccharide they produce, and these types vary in their virulence, prevalence, and drug resistance. The organism naturally colonizes the upper respiratory tract, including the sinuses and nasal cavity, often without causing symptoms in healthy carriers. It spreads through direct contact via respiratory droplets or by auto-inoculation from the upper respiratory tract. In susceptible individuals, such as the elderly and young children, it can become pathogenic, causing a wide range of invasive diseases including community-acquired pneumonia, meningitis, sepsis, and numerous other infections like otitis media, sinusitis, and endocarditis. It is also a notable cause of neonatal infections and sepsis in those with HIV. S. pneumoniae can be distinguished from other alpha-hemolytic streptococci by its sensitivity to optochin and its solubility in bile.

Reader's Guide

Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and meningitis in children and the elderly, as well as sepsis in those infected with HIV. It causes a wide range of invasive pneumococcal diseases, including bronchitis, otitis media, and endocarditis. Its genome contains between 2.0 and 2.1 million base pairs, and natural transformation—a process requiring at least 23 genes—allows it to take up exogenous DNA, which may aid in repairing oxidative DNA damage from host immune responses. The organism's ability to undergo phase variation between transparent and opaque colony phenotypes helps it survive in different human body systems. Its historical role in demonstrating that DNA is the genetic material remains a landmark in molecular biology.

Did You Know?

• Streptococcus pneumoniae cells are usually found in pairs (diplococci) and do not form spores.
• The organism can be differentiated from viridans streptococci using an optochin test, as S. pneumoniae is optochin-sensitive.

History & Discovery

Perhaps its most consequential legacy, however, lies in the history of genetics. Fourteen years later, Oswald Avery, Colin MacLeod, and Maclyn McCarty identified the transforming factor as DNA rather than protein, a finding that launched the molecular era of genetics.

Capsule & Virulence Machinery

The defining weapon of Streptococcus pneumoniae is its polysaccharide capsule, a viscous outermost layer anchored to the peptidoglycan cell wall. This capsule is assembled from high-molecular-weight polymers of repeating oligosaccharide units covalently bonded to the cell surface, and it functions as a formidable shield against the host immune system. By physically blocking granulocytes from reaching the cell wall, the capsule effectively inhibits phagocytosis, granting the bacterium a critical survival advantage. Beyond the capsule, the organism deploys additional virulence tools including pneumolysin, various adhesins, and immunogenic cell wall components. Together, these factors determine whether a colonizing strain remains harmless in the respiratory tract or invades deeper tissues to cause serious disease.

Clinical Impact & Disease Spectrum

Although Streptococcus pneumoniae routinely colonizes the nasal cavity, sinuses, and respiratory tract of healthy carriers without provoking symptoms, it becomes a serious threat when the host's immune defenses are weakened, particularly in the elderly and young children. Transmission occurs through direct person-to-person contact via respiratory droplets, and auto-inoculation from the upper airways can seed infection at distant sites. The bacterium is the principal cause of community-acquired pneumonia and meningitis in children and older adults, and it drives sepsis in individuals living with HIV. Its disease spectrum extends far beyond the lungs: invasive pneumococcal infections encompass bronchitis, acute sinusitis, otitis media, conjunctivitis, osteomyelitis, septic arthritis, endocarditis, peritonitis, pericarditis, cellulitis, and brain abscess. It can even cause neonatal infections. The sheer breadth of this clinical picture underscores why pneumococcus has long been a central subject of humoral immunity research.

Genetics & Natural Transformation

Genetic variation between strains can reach ten percent, and the genome harbors a diverse arsenal of antimicrobial peptides, including eleven distinct lantibiotics. One of the organism's most remarkable capabilities is natural transformation — the uptake and recombination of exogenous DNA from the surrounding medium. This process demands a specialized physiological state called competence, governed by at least 23 genes, and is triggered by DNA-damaging agents such as fluoroquinolone antibiotics and topoisomerase inhibitors. Research by Michod and colleagues suggests that competence induction is an adaptive response to oxidative stress, boosting RecA-mediated recombinational repair. Because host granulocytes generate a potentially lethal oxidative burst during infection, the ability to repair this damage likely enhances virulence. Li and others confirmed that nasal colonization fitness and lung infectivity depend on an intact competence system.